Cryptomeria japonica-Induced Allergic Conjunctivitis in Mice

Efficacy of oral immunotherapy with a rice-based edible vaccine containing hypoallergenic Japanese cedar pollen allergens for treatment of established allergic conjunctivitis in mice

BACKGROUND

We have previously shown that prophylactic oral administration of transgenic rice seeds expressing hypoallergenic modified antigens suppressed the development of allergic conjunctivitis induced by Japanese cedar pollen. We have now investigated the efficacy of oral immunotherapy with such transgenic rice for established allergic conjunctivitis in mice.

METHODS

BALB/c mice were sensitized with two intraperitoneal injections of Japanese cedar pollen in alum, challenged with pollen in eyedrops, and then fed for 16 days with transgenic rice seeds expressing modified Japanese cedar pollen allergens Cry j 1 and Cry j 2 or with nontransgenic rice seeds as a control. They were then challenged twice with pollen in eyedrops, with clinical signs being evaluated at 15 min after the first challenge and the eyes, blood, spleen, and lymph nodes being isolated at 24 h after the second challenge.

RESULTS

The number of eosinophils in the conjunctiva and the clinical score for conjunctivitis were both significantly lower in mice fed the transgenic rice than in those fed nontransgenic rice. Oral vaccination with transgenic rice seeds also resulted in a significant increase in the production of IFN-γ by splenocytes, whereas it had no effect on the number of CD4⁺CD25⁺Foxp3⁺ regulatory T cells in the spleen or submandibular or mesenteric lymph nodes.

CONCLUSIONS

Oral administration of transgenic rice seeds expressing hypoallergenic allergens ameliorated allergic conjunctivitis in the established setting. Such a rice-based edible vaccine is potentially both safe and effective for oral immunotherapy in individuals with allergic conjunctivitis.

Prevention of allergic conjunctivitis in mice by a rice-based edible vaccine containing modified Japanese cedar pollen allergens

BACKGROUND/AIMS

To determine whether oral immunotherapy with transgenic rice seeds expressing hypoallergenic modified antigens suppresses cedar pollen-induced allergic conjunctivitis by eliciting immune tolerance in mice.

METHODS

BALB/c mice were fed once a day for 20 days with 220 mg of transgenic rice expressing modified Japanese cedar pollen allergens Cry j 1 and Cry j 2 or with non-transgenic rice seeds as a control. They were then sensitised with two intraperitoneal injections of Japanese cedar pollen in alum before challenge twice with pollen in eye drops. Twenty-four hours after the second challenge, the conjunctiva, spleen, and blood were isolated for histological analysis, cytokine production assays, and measurement of serum immunoglobulin E concentrations, respectively.

RESULTS

The numbers of eosinophils and total inflammatory cells in the conjunctiva were significantly lower in mice fed the transgenic rice than in those fed non-transgenic rice. The clinical score evaluated at 15 min after antigen challenge was also significantly lower in mice fed the transgenic rice than in those fed non-transgenic rice. The serum concentrations of both total and allergen-specific immunoglobulin E were also significantly lower in mice fed the transgenic rice. Oral vaccination with transgenic rice resulted in significant down-regulation of the allergen-induced production of interleukin (IL)-2, IL-4, IL-5, IL-12p70, interferon-γ, and IL-17A by splenocytes.

CONCLUSIONS

Oral immunotherapy with transgenic rice expressing modified Japanese cedar pollen allergens suppressed pollen-induced experimental allergic conjunctivitis in mice by eliciting immune tolerance. This novel prophylactic approach is potentially safe and effective for allergen-specific oral immunotherapy in allergic conjunctivitis.

Image analyses of the kinetic changes of conjunctival hyperemia in histamine-induced conjunctivitis in Guinea pigs

BACKGROUND

Conjunctival hyperemia is the most common finding in patients with allergic conjunctivitis. Histamine is a typical chemical mediator involved in allergic conjunctivitis and induces hyperemia. Here, we investigated the kinetic changes in bulbar hyperemia induced by histamine in eyedrops.

METHODS

Male guinea pigs were challenged with histamine in eyedrops. Bulbar conjunctival images were taken every 10 seconds by a digital camera up to 8 minutes after histamine challenge, and the software program ImageJ was used to analyze the images. Images were binarized, and a region of interest unobscured by corneal and scleral vessels was selected as the evaluation area. Evaluations were carried out before and after histamine challenge by counting the numbers of absolute pixel values, percent changes in pixels, or the fractal dimension in acquired images.

RESULTS

After histamine challenge, the conjunctival vessel area continued to increase up to 5 minutes before stabilizing. The various parameters used to evaluate the images (numbers of absolute pixel values, percent change in pixels, or the fractal dimensions) markedly increased 1 minute after histamine challenge, gradually increased up to 5 minutes, and then gradually decreased before reaching a level that remained significantly higher than that before histamine challenge.

CONCLUSIONS

This is the first report to quantitatively evaluate bulbar hyperemia induced by histamine using image analysis. The development of software that can automatically yield meaningful values for hyperemia from hyperemia images will be a useful objective tool in clinical trials for evaluation of drug effects in animal models and in humans.